AnalystsThomas ShraderThomas Shrader's Stock Forecasts
AnalystsThomas Shrader
Analyst Ranking
Bottom 5%
#5038 out of 5298 analysts
Average Return
-4.19%
Win Rate
38%40 out of 106
Risk vs Reward
Poor
Good
Thomas Shrader's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ovid Therapeutics IncOVID | +474.32% | $0.44 | $2.55 | 2025-03-23 - 2026-03-23 | Strong Buy |
Annexon IncANNX | +136.19% | $2.10 | $4.96 | 2023-05-24 - 2024-05-24 | Strong Buy |
Nrx Pharmaceuticals IncNRXP | +123.66% | $1.78 | $3.97 | 2026-02-17 - 2026-06-16 | Strong Buy |
Inmune Bio IncINMB | +117.73% | $10.38 | $22.60 | 2020-08-31 - 2021-08-30 | Strong Buy |
Biohaven LtdBHVN | +101.08% | $16.74 | $33.66 | 2022-12-01 - 2023-12-01 | Strong Buy |
Thomas Shrader Analyst Color
Get additional color on Thomas Shrader's coverage of popular stocks
Thomas Shrader's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Novavax IncNVAX | 2 | Strong Buy | $19.00 | +106.52% | Reiterates | 6 days ago |
Invivyd IncIVVD | 6 | Strong Buy | $10.00 | +1,021.08% | Reiterates | 8 days ago |
Neonc Technologies Holdings IncNTHI | 2 | Strong Buy | $15.00 | +189.58% | Reiterates | 22 days ago |
Compass Pathways PLCCMPS | 3 | Strong Buy | $14.00 | +21.85% | Reiterates | a month ago |
Bioage Labs IncBIOA | 1 | Strong Buy | $40.00 | +95.22% | Initiates Coverage On | a month ago |
Harrow IncHROW | 6 | Strong Buy | $63.00 | +64.06% | Reiterates | a month ago |
Denali Therapeutics IncDNLI | 6 | Strong Buy | $39.00 | +77.84% | Reiterates | a month ago |
Stoke Therapeutics IncSTOK | 4 | Strong Buy | $39.00 | +33.79% | Reiterates | a month ago |
Ac Immune SaACIU | 5 | Strong Buy | $8.00 | +237.55% | Reiterates | a month ago |
Bright Minds Biosciences IncDRUG | 5 | Strong Buy | $147.00 | N/A | Reiterates | 3 months ago |
Acumen Pharmaceuticals IncABOS | 5 | Strong Buy | $8.00 | +249.34% | Reiterates | 3 months ago |
Ovid Therapeutics IncOVID | 4 | Strong Buy | $4.00 | +69.49% | Reiterates | 3 months ago |
Nrx Pharmaceuticals IncNRXP | 4 | Strong Buy | $25.00 | +529.72% | Reiterates | 3 months ago |
Alector IncALEC | 4 | Strong Buy | $6.00 | +289.61% | Upgrades | 3 months ago |
Opus Genetics IncIRD | 3 | Strong Buy | $12.00 | +207.69% | Maintains | 4 months ago |
Vaxcyte IncPCVX | 8 | Strong Buy | $89.00 | +80.49% | Maintains | 4 months ago |
Alto Neuroscience IncANRO | 2 | Strong Buy | $28.00 | +33.33% | Maintains | 4 months ago |
Biohaven LtdBHVN | 4 | Strong Buy | $16.00 | +32.34% | Reiterates | 7 months ago |
Coya Therapeutics IncCOYA | 3 | Strong Buy | $16.00 | +231.95% | Maintains | 7 months ago |
Aldeyra Therapeutics IncALDX | 2 | Strong Buy | $9.00 | +405.62% | Reiterates | 7 months ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Strong Buy | $23.00 | +222.13% | Maintains | 8 months ago |
Gain Therapeutics IncGANX | 4 | Strong Buy | $9.00 | +402.79% | Reiterates | 8 months ago |
Promis Neurosciences IncPMN | 1 | Strong Buy | $200.00 | N/A | Initiates Coverage On | 3 years ago |
Precision Biosciences IncDTIL | 1 | Strong Buy | $60.00 | N/A | Maintains | 3 years ago |
Annexon IncANNX | 2 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Leonabio IncLONA | 2 | Strong Buy | $100.00 | N/A | Maintains | 3 years ago |
Bioatla IncBCAB | 3 | Strong Buy | $650.00 | N/A | Maintains | 3 years ago |
Verona Pharma PLCVRNA | 3 | Strong Buy | $31.00 | N/A | Maintains | 3 years ago |
Sqz Biotechnologies CoSQZB | 2 | Strong Buy | $15.00 | N/A | Maintains | 4 years ago |
Inmune Bio IncINMB | 2 | Strong Buy | $14.00 | N/A | Maintains | 4 years ago |
Sigilon Therapeutics IncSGTX | 1 | Strong Buy | $182.00 | N/A | Initiates Coverage On | 5 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $51.00 | N/A | Initiates Coverage On | 5 years ago |
Celularity IncCELU | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Oncosec Medical IncONCSQ | 1 | Strong Buy | $220.00 | N/A | Initiates Coverage On | 5 years ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Voyager Therapeutics IncVYGR | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
89bio IncETNB | 1 | Strong Buy | $58.00 | N/A | Maintains | 6 years ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | 6 years ago |
Geron CorpGERN | 1 | Strong Buy | $3.00 | N/A | Maintains | 6 years ago |
Acorda Therapeutics IncACORQ | 1 | Hold | $840.00 | N/A | Maintains | 7 years ago |
Biogen IncBIIB | 3 | Hold | $346.00 | N/A | Downgrades | 7 years ago |
Momenta Pharmaceuticals IncMNTA | 2 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Kite Pharma IncKITE | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.